These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 16836785)

  • 1. Neuroimmunology of dancing eye syndrome in children.
    Wilson J
    Dev Med Child Neurol; 2006 Aug; 48(8):693-6. PubMed ID: 16836785
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Opsoclonus-ataxia caused by childhood neuroblastoma: developmental and neurologic sequelae.
    Mitchell WG; Davalos-Gonzalez Y; Brumm VL; Aller SK; Burger E; Turkel SB; Borchert MS; Hollar S; Padilla S
    Pediatrics; 2002 Jan; 109(1):86-98. PubMed ID: 11773546
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Opsoclonus myoclonus syndrome in neuroblastoma a report from a workshop on the dancing eyes syndrome at the advances in neuroblastoma meeting in Genoa, Italy, 2004.
    Matthay KK; Blaes F; Hero B; Plantaz D; De Alarcon P; Mitchell WG; Pike M; Pistoia V
    Cancer Lett; 2005 Oct; 228(1-2):275-82. PubMed ID: 15922508
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neuro-ophthalmologic manifestations of paraneoplastic syndromes.
    Ko MW; Dalmau J; Galetta SL
    J Neuroophthalmol; 2008 Mar; 28(1):58-68. PubMed ID: 18347462
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Longitudinal neurodevelopmental evaluation of children with opsoclonus-ataxia.
    Mitchell WG; Brumm VL; Azen CG; Patterson KE; Aller SK; Rodriguez J
    Pediatrics; 2005 Oct; 116(4):901-7. PubMed ID: 16199699
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term neurobehavioral outcomes in children with neuroblastoma and opsoclonus-myoclonus-ataxia syndrome: relationship to MRI findings and anti-neuronal antibodies.
    Hayward K; Jeremy RJ; Jenkins S; Barkovich AJ; Gultekin SH; Kramer J; Crittenden M; Matthay KK
    J Pediatr; 2001 Oct; 139(4):552-9. PubMed ID: 11598603
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Functional characterisation of autoantibodies from patients with pediatric opsoclonus-myoclonus-syndrome.
    Korfei M; Fühlhuber V; Schmidt-Wöll T; Kaps M; Preissner KT; Blaes F
    J Neuroimmunol; 2005 Dec; 170(1-2):150-7. PubMed ID: 16203043
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Opsoclonus-myoclonus associated with celiac disease.
    Deconinck N; Scaillon M; Segers V; Groswasser JJ; Dan B
    Pediatr Neurol; 2006 Apr; 34(4):312-4. PubMed ID: 16638509
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Surface-binding autoantibodies to cerebellar neurons in opsoclonus syndrome.
    Blaes F; Fühlhuber V; Korfei M; Tschernatsch M; Behnisch W; Rostasy K; Hero B; Kaps M; Preissner KT
    Ann Neurol; 2005 Aug; 58(2):313-7. PubMed ID: 15988749
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Myoclonic encephalopathy of infants or "dancing eyes syndrome". Report of 7 cases with long-term follow-up and review of the literature (cases with and without neuroblastoma).
    Boltshauser E; Deonna T; Hirt HR
    Helv Paediatr Acta; 1979 May; 34(2):119-33. PubMed ID: 222713
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Myoclonic encephalopathy. ("Dancing eyes" syndrome with myoclonic ataxia).
    Gross-Selbeck G; Goll U
    Klin Padiatr; 1972 Sep; 184(5):393-9. PubMed ID: 4343942
    [No Abstract]   [Full Text] [Related]  

  • 12. Opsoclonus/myoclonus: paraneoplastic syndrome of neuroblastoma.
    Janss A; Sladky J; Chatten J; Johnson J
    Med Pediatr Oncol; 1996 Apr; 26(4):272-9. PubMed ID: 8600342
    [No Abstract]   [Full Text] [Related]  

  • 13. [Autoimmune mechanisms in paraneoplastic neurological diseases: the paradigm of opsoclonus myoclonus ataxia syndrome].
    Ovadia H; Karussis D; Abramsky O
    Harefuah; 2006 Apr; 145(4):298-303, 317. PubMed ID: 16642634
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Childhood opsoclonus myoclonus.
    Dale RC
    Lancet Neurol; 2003 May; 2(5):270. PubMed ID: 12849175
    [No Abstract]   [Full Text] [Related]  

  • 15. Hypothalamic dysfunction associated with neuroblastoma: evidence for a new Paraneoplastic syndrome?
    Sirvent N; Bérard E; Chastagner P; Feillet F; Wagner K; Sommelet D
    Med Pediatr Oncol; 2003 May; 40(5):326-8. PubMed ID: 12652624
    [No Abstract]   [Full Text] [Related]  

  • 16. Neuroepidemiologic trends in 105 US cases of pediatric opsoclonus-myoclonus syndrome.
    Tate ED; Allison TJ; Pranzatelli MR; Verhulst SJ
    J Pediatr Oncol Nurs; 2005; 22(1):8-19. PubMed ID: 15574722
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Opsoclonus myoclonus syndrome: how long are we going to go on researching?].
    Ramos S; Temudo T
    Rev Neurol; 2002 Aug 16-31; 35(4):322-5. PubMed ID: 12235560
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Improvement of neurological status and quality of life in children with opsoclonus myoclonus syndrome at long-term follow-up.
    Catsman-Berrevoets CE; Aarsen FK; van Hemsbergen ML; van Noesel MM; Hakvoort-Cammel FG; van den Heuvel-Eibrink MM
    Pediatr Blood Cancer; 2009 Dec; 53(6):1048-53. PubMed ID: 19672966
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Opsomyoclonus syndrome in children. A new case. Review of the literature (110 cases)].
    Talon P; Stoll C
    Pediatrie; 1985 Sep; 40(6):441-9. PubMed ID: 3835536
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Opsoclonus-myoclonus syndrome.
    Pike M
    Handb Clin Neurol; 2013; 112():1209-11. PubMed ID: 23622330
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.